GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Turk Ilac ve Serum Sanayi (IST:TRILC) » Definitions » Enterprise Value

Turk Ilac ve Serumnayi (IST:TRILC) Enterprise Value : ₺5,139 Mil (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Turk Ilac ve Serumnayi Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Turk Ilac ve Serumnayi's Enterprise Value is ₺5,139 Mil. Turk Ilac ve Serumnayi's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was ₺225 Mil. Therefore, Turk Ilac ve Serumnayi's EV-to-EBIT ratio for today is 22.83.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Turk Ilac ve Serumnayi's Enterprise Value is ₺5,139 Mil. Turk Ilac ve Serumnayi's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₺242 Mil. Therefore, Turk Ilac ve Serumnayi's EV-to-EBITDA ratio for today is 21.24.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Turk Ilac ve Serumnayi's Enterprise Value is ₺5,139 Mil. Turk Ilac ve Serumnayi's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was ₺1,207 Mil. Therefore, Turk Ilac ve Serumnayi's EV-to-Revenue ratio for today is 4.26.


Turk Ilac ve Serumnayi Enterprise Value Historical Data

The historical data trend for Turk Ilac ve Serumnayi's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turk Ilac ve Serumnayi Enterprise Value Chart

Turk Ilac ve Serumnayi Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Enterprise Value
Get a 7-Day Free Trial - - - 2,045.54 2,454.79

Turk Ilac ve Serumnayi Quarterly Data
Dec17 Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,833.42 2,454.79 1,658.85 1,836.05 2,842.91

Competitive Comparison of Turk Ilac ve Serumnayi's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Turk Ilac ve Serumnayi's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Turk Ilac ve Serumnayi's Enterprise Value falls into.



Turk Ilac ve Serumnayi Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Turk Ilac ve Serumnayi's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as

Turk Ilac ve Serumnayi's Enterprise Value for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turk Ilac ve Serumnayi  (IST:TRILC) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Turk Ilac ve Serumnayi's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=5138.925/225.102
=22.83

Turk Ilac ve Serumnayi's current Enterprise Value is ₺5,139 Mil.
Turk Ilac ve Serumnayi's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺225 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Turk Ilac ve Serumnayi's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=5138.925/241.921
=21.24

Turk Ilac ve Serumnayi's current Enterprise Value is ₺5,139 Mil.
Turk Ilac ve Serumnayi's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺242 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Turk Ilac ve Serumnayi's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=5138.925/1206.911
=4.26

Turk Ilac ve Serumnayi's current Enterprise Value is ₺5,139 Mil.
Turk Ilac ve Serumnayi's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺1,207 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turk Ilac ve Serumnayi Enterprise Value Related Terms

Thank you for viewing the detailed overview of Turk Ilac ve Serumnayi's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Turk Ilac ve Serumnayi (IST:TRILC) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Bügduz Mah. Enver Pasa Cad., No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.

Turk Ilac ve Serumnayi (IST:TRILC) Headlines

No Headlines